AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,353,944 | +61.5% | 46,539 | +22.2% | 0.00% | 0.0% |
| Q2 2023 | $1,457,323 | 0.0% | 38,090 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,457,323 | -26.1% | 38,090 | +5.9% | 0.00% | 0.0% |
| Q4 2022 | $1,971,102 | -99.8% | 35,969 | +46.2% | 0.00% | – |
| Q3 2022 | $837,937,000 | +161.8% | 24,609 | -27.3% | 0.00% | – |
| Q2 2022 | $320,090,000 | +21.0% | 33,872 | +81.7% | 0.00% | – |
| Q1 2022 | $264,502,000 | +24.9% | 18,640 | +155.3% | 0.00% | – |
| Q1 2021 | $211,773,000 | -2.3% | 7,300 | -13.1% | 0.00% | – |
| Q4 2020 | $216,720,000 | -16.2% | 8,400 | 0.0% | 0.00% | – |
| Q3 2020 | $258,636,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |